ThriveAI | $1,200,000 | (May 14, 2025)
Optimal Dynamics | $40,000,000 | (May 14, 2025)
Remedy Plan Therapeutics | $18,000,000 | (May 14, 2025)
Adopt AI
United States
- San Jose, California
- 14/05/2025
- Seed
- $6,000,000
Adopt AI helps modern applications deliver an agentic experience to their end users within days. Using Adopt, end users of applications can execute complex actions across their applications via natural language commands, automate workflows, and unlock new possibilities for application innovation.
In this future, AI agents will understand application/website workflows, know which components to call, create dynamic plans, and execute those plans to achieve desired outcomes. This approach means that humans will no longer need to learn how to use applications; instead, they can interact with AI in natural language to accomplish tasks or have AI automatically perform tasks based on schedules or triggers. Adopt AI is helping companies race against time to build their own AI copilot and set of autonomous/semi-autonomous agents. This is required to stay relevant, change along with changing human needs, keep adoption high, churn low, and retain high NPS and GRR/NRR.
- Industry Technology, Information and Internet
- Website https://www.adopt.ai/
- LinkedIn https://www.linkedin.com/company/getadoptai/
Related People
Deepak AnchalaCo Founder
United States -
San Jose, California
I’m the founder of Adopt.ai, where we help applications launch their agentic experience, empowering their users to get jobs done using natural language commands.
Before this, I founded Slintel, a go-to-market intelligence platform used by 300+ customers globally.
We scaled it to acquisition by 6sense, where I led product as VP.
2X founder. Operator. Now building in the Agentic AI space.
ClearVector | $13,000,000 | (May 14, 2025)
Pluto Bio | $3,600,000 | (May 14, 2025)
Somite AI | Undisclosed Amount | (May 14, 2025)
Stackpack | $6,300,000 | (May 14, 2025)
veritree | $6,500,000 | (May 14, 2025)
theom | $20,000,000 | (May 13, 2025)
InBrain Pharma | $2,000,943 | (May 13, 2025)